Tiludronate therapy for Paget's disease of bone

Bone

Volumn 17, Issue 5 SUPPL. 1, 1995, Pages

  McClung, M R ^a,b,c   Tou, C K P ^a,b,c   Goldstein, N H ^a,b,c   Picot, C ^a,b,c  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

^b Dept of Preclinical Biostatistics   (United States)

^c SANOFI   (France)

Author keywords

Bisphosphonates; Paget's disease; Tiludronate

Indexed keywords

ALKALINE PHOSPHATASE ISOENZYME; PLACEBO; TILUDRONIC ACID;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; PAGET BONE DISEASE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE RESORPTION; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEITIS DEFORMANS;

EID: 0028871450     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(95)00282-1     Document Type: Article

References (13)

1. Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate
2. In vitro and in vivo osseous pharmacological profile of tiludronate. Implications for osteoporosis treatment
3. Histomorphometric analysis of bone biopsies of baboons treated with SR41319B, a new diphosphonate
4. Experimental basis for the use of bisphosphonates in Paget's disease of bone
5. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate
6. Measurement of pain
7. Long term follow-up observations on therapy in Paget's disease of bone
8. Treating Pagetʼs Disease of Bone
9. Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone
10. Biological and clinical assessment of a new bisphosphonate, (chloro-4-phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of bone
11. Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double blind, multiple dosage, placebo controlled study
12. Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis
13. Comparative prospective double-blind multicenter study of the efficacy of tiludronate and etidronate in Paget's disease of bone